NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/24/2024
Back to search
Official data from USPTO
IBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
09/24/2024
Trademark type
Combined
Nice classes
42
Filing date
07/19/2023
Registration date
09/24/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/24/2024
Last transaction
09/24/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/11/2023
First use in commerce
07/11/2023
Drawing code
3
Owner type
03
Owner location
San Diego, CA
Examiner
BONEN-CLARK, HOPE
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of stylized word "IBIO", with the dot in the second "I" in the form of a double helix forming an infinity image, with arrow images in the interior of one side of the infinity form, and an image of carbons inside the other side of the infinity image.
Holders and representatives
Holders
iBio, Inc
Representatives
Daniel Chalker CHALKER FLORES, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical peptideproteinantibodychimeric antibody or protein drug development services; Pharmaceutical peptideproteinantibodychimeric antibodies or proteins product development; Pharmaceutical research and development of peptidesproteinsantibodieschimeric antibodies or proteins; Conducting early evaluations in the field of new peptideproteinantibodychimeric antibody or protein based pharmaceuticals; Development of peptideproteinantibodychimeric antibody or protein based pharmaceutical preparations and medicines; Laboratory peptide and protein based research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development of peptideproteinantibodychimeric antibody or protein based pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of peptideproteinantibodychimeric antibody or protein based pharmaceuticals; Research on the subject of peptideproteinantibodychimeric antibody or protein based pharmaceuticals; Technical research in the field of peptideproteinantibodychimeric antibody or protein based pharmaceutical studies; Testinginspection or research of pharmaceuticalscosmetics or foodstuff made with peptidesproteinsantibodieschimeric antibodies or proteins; Research and development in the pharmaceutical and biotechnology fields; Research and development regarding pharmaceuticalsproteinsantibodies; platform-as-a-service (PaaS) featuring computer software platforms for protein analysis and discovery of antibody-based drugs; Software as a service (SAAS) services featuring software for designing molecule libraries for the purposes of generating products in the field of pharmaceuticalsbiotechnologymedicine; Computer software development in the field of artificial intelligencebiotechnologypharmaceuticalsmedical applications; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing on-line non-downloadable software using artificial intelligence for use in facilitating product development in the field of biotechnologypharmaceuticalsmedicine; Scientific research for medical purposes in the area of cancerous diseases; Software as a service (SAAS) services featuring software using artificial intelligence for use in facilitating product development in the field of biotechnologypharmaceuticalsmedicine; Technical consulting in the field of pharmaceutical studies; Technology consultation in the field of artificial intelligence; Testing of pharmaceuticals; Testinginspection or research of pharmaceuticalscosmetics or foodstuff; Providing medical testing services and information in the field of cancer research and disease classification; Providing information about medical research in the field of artificial intelligencemedical biotechnologypharmaceuticals
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/24/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2024
PUBO
PUBLISHED FOR OPPOSITION
07/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/19/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/30/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/26/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/26/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/26/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/08/2024
GNRT
NON-FINAL ACTION E-MAILED
04/08/2024
CNRT
NON-FINAL ACTION WRITTEN
04/08/2024
DOCK
ASSIGNED TO EXAMINER
03/25/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/28/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/28/2023
ALIE
ASSIGNED TO LIE
12/28/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/18/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/17/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/01/2023
NWAP
NEW APPLICATION ENTERED
07/22/2023
Continuous trademark protection
Get notified about every new filing that threatens IBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.